MYSTERIOUS NEW BLOOD BACTERIA SEEMS LIKE NANOBOT BIOWEAPON

Dr. Nick Delgado is a researcher of biochemistry and endocrinology, with a special focus on anti-aging medicine. In this clip, Dr. Delgado speaks to me about a disturbing new phenomenon that he’s been observing for about a year and a half.

When he examines patients, Dr. Delgado puts a drop of their blood beneath a microscope. After 40 years of studying blood morphology, he has never previously seen or heard of the 1-micron-sized* tiny “tadpoles”, which he’s been seeing lately, which school like fish in large groups around the blood cells, moving in unison and changing rapidly in direction. The people carrying these “tadpoles” all describe having a persistent cough.

These “tadpoles” somewhat resemble a class of microbe called flagella. A common example of a flagellate bacterium is the ulcer-causing Helicobacter pylori – however, these “tadpoles” behave differently from anything he’s ever seen.

Dr. Delgado isn’t sure whether these are a “super” bacteria or exactly what they are but he’s encountered cases in Northern- and Southern California, as well as in Florida. After I suggested that if they were not readily identifiable as microbes, that these might be some sort of bioweapon, he remarked that he was open to this possibility.

Everybody seems to forget that a while ago “Scientists Work To Destroy Old Polio Vaccine After Admitting it Causes Polio”

Everybody seems to forget that a while ago “Scientists Work To Destroy Old Polio Vaccine After Admitting it Causes Polio”

Polio Vaccines Now The #1 Cause of Polio Paralysis
According to the Polio Global Eradication Initiative’s own statistics2 there were 42 cases of wild-type polio (WPV) reported in India in 2010, indicating that vaccine-induced cases of polio paralysis (100-180 annually) outnumber wild-type cases by a factor of 3-4. Even if we put aside the important question of whether or not the PGEI is accurately differentiating between wild and vaccine-associated polio cases in their statistics, we still must ask ourselves: should not the real-world effects of immunization, both good and bad, be included in PGEI’s measurement of success? For the dozens of Indian children who develop vaccine-induced paralysis every year, the PGEI’s recent declaration of India as nearing “polio free” status, is not only disingenuous, but could be considered an attempt to minimize their obvious liability in having transformed polio from a natural disease vector into a man-made (iatrogenic) one.

Shock: Scientists Work To Destroy Old Polio Vaccine After Admitting it Causes Polio
“Some of that virus could leak out into the world, and we could have outbreaks of a type of polio we haven’t seen since 1999″
Clinics around the world are destroying an old, problematic polio vaccine in favor of a new oral one, in an unprecedented effort that has never before been attempted.
The problem with the old vaccine? It was causing polio. Oops.
The massive global eradication effort takes place within the next few weeks at thousands of sites in 155 different countries, and requires a complete destruction of every single vial of the vaccine for the worldwide plan to work.
“Health workers have been taught to destroy the old vaccine by boiling it, incinerating it, even burying it in the ground,” reports NPR.org.

New Polio Vaccine Rolled Out In Massive Synchronized Worldwide Switch
As health officials strategize about how to rid the world of the disease, which can cause paralysis, “one important step is to gradually withdraw the oral polio vaccine, starting with the type 2 component,” Jackie Fournier-Caruana from the initiative explains.
The old oral vaccine (tOPV) protected against three strains of poliovirus, while the new oral vaccine (bOPV) protects against two of the strains. According to the initiative, the transition is possible “because type 2 wild polio has been eradicated.”
It stresses the importance of closely synchronizing this transition globally: “if some countries continue to use tOPV it could increase the risk of the spread of type 2 poliovirus to those no longer using tOPV.”

Replacing trivalent OPV with bivalent OPV
Objective 2 of the Polio Eradication and Endgame Strategic Plan 2013-2018 calls for an important transition in the vaccines used to eradicate polio and requires the removal of all oral polio vaccines (OPVs) in the long term. This will eliminate the rare risks of vaccine-associated paralytic polio (VAPP) and circulating vaccine-derived poliovirus (cVDPV).
The withdrawal of OPVs must occur in a globally synchronized manner, starting in April 2016 with a switch from trivalent OPV (tOPV) to bivalent OPV (bOPV), removing the type 2 component (OPV2) from immunization programmes.
If not already underway, planning for OPV cessation must start now, while efforts are being intensified to interrupt transmission of the remaining strains of wild poliovirus.
Preparation for the removal of OPVs also includes the introduction of at least one dose of inactivated polio vaccine (IPV) into routine immunization programmes in all countries by the end of 2015.